CHRIST HOSPITAL
1. Target Overview & Investment Thesis
CHRIST HOSPITAL is a 163-bed under-performing / distressed in nan, NJ with $117.8M in net patient revenue and a -51.8% operating margin. The hospital serves a payer mix of 17.7% Medicare, 2.3% Medicaid, and 80.1% commercial.
Thesis: Undervalued. Our ML models identify $8.7M in annual EBITDA improvement potential from RCM optimization across 5 levers, lifting margin from -51.8% to -44.5% (+736bps).
| Net Revenue HCRIS | $117.8M |
| Current EBITDA COMPUTED | $-61.0M |
| Operating Margin COMPUTED | -51.8% |
| Occupancy HCRIS | 57.5% |
| Revenue / Bed COMPUTED | $723K |
| Net-to-Gross HCRIS | 3.6% |
| Distress Probability ML | 43.5% |
2. Market Context & Competitive Position
NJ has 95 Medicare-certified hospitals with a median operating margin of -3.9%. The target's margin of -51.8% places it below the state median. Among 51 size-comparable peers (82-326 beds), the median margin is -3.2%. The target's below-peer margin suggests operational improvement opportunity.
3. RCM Performance Analysis — Comparable Hospitals
Comps selected by bed count (82-326), prioritizing same-state peers. 51 hospitals in the comp set.
| Hospital | State | Beds | Revenue | Margin |
|---|---|---|---|---|
| CHRIST HOSPITAL (Target) | NJ | 163 | $117.8M | -51.8% |
| ENGLEWOOD HOSPITAL & MED CTR | NJ | 292 | $967.3M | 0.1% |
| CAPITAL HEALTH MED CENTER - HO | NJ | 209 | $746.8M | 0.8% |
| PRINCETON HEALTHCARE SYSTEM | NJ | 206 | $587.8M | -5.7% |
| INSPIRA MEDICAL CENTER VINELAN | NJ | 280 | $505.5M | -12.0% |
| HOLY NAME HOSPITAL | NJ | 289 | $493.4M | 8.1% |
| JERSEY CITY MEDICAL CENTER | NJ | 289 | $456.8M | -13.7% |
| MONMOUTH MEDICAL CENTER | NJ | 240 | $448.7M | -10.8% |
| VIRTUA OUR LADY OF LOURDES HOS | NJ | 290 | $445.2M | 2.4% |
4. Predicted Improvement Opportunities
Improvement targets set at P75 of comparable peers with 60% gap closure assumption. Coefficients calibrated to published research bands. Total EBITDA uplift: $8.7M (736bps margin improvement).
| Lever | Current | Target | EBITDA Impact | Margin | Ramp |
|---|---|---|---|---|---|
| Net Collection Rate | 93.5% | 97.0% | $2.5M | +210bp | 18mo |
| Cost to Collect | 4.5% | 2.5% | $2.4M | +200bp | 12mo |
| Denial Rate Reduction | 12.0% | 6.5% | $2.3M | +198bp | 12mo |
| A/R Days Reduction | 5200.0% | 3800.0% | $1.4M | +122bp | 9mo |
| Clean Claim Rate | 88.0% | 96.0% | $75K | +6bp | 6mo |
5. EBITDA Bridge
| Current EBITDA | $-61.0M |
| + RCM Uplift | +$8.7M |
| Pro Forma EBITDA | $-52.4M |
| Current Margin | -51.8% |
| Pro Forma Margin | -44.5% |
| WC Released (1x) | $4.5M |
6. Returns Analysis — Scenario Matrix
5-year hold, 5.5x leverage, 3% organic growth, 10%/yr debt paydown. Base case uses 100% of predicted RCM uplift. Bull case: 130% uplift at lower entry. Bear case: 50% uplift at higher entry.
| Scenario | Entry | Exit | Equity In | Equity Out | MOIC | IRR |
|---|---|---|---|---|---|---|
| Base Case | 10.0x | 10.0x | $-93.9M | $-315.9M | 0.00x | -100.0% |
| Base (11x exit) | 10.0x | 11.0x | $-93.9M | $-378.0M | 0.00x | -100.0% |
| Bull Case | 9.0x | 11.0x | $-84.5M | $-379.9M | 0.00x | -100.0% |
| Bull (12x exit) | 9.0x | 12.0x | $-84.5M | $-439.4M | 0.00x | -100.0% |
| Bear Case | 11.0x | 10.0x | $-103.3M | $-328.8M | 0.00x | -100.0% |
| Bear (11x exit) | 11.0x | 11.0x | $-103.3M | $-395.2M | 0.00x | -100.0% |
7. Key Risks & Mitigants
| Severity | Risk Factor | Mitigant |
|---|---|---|
| High | Negative operating margin | RCM uplift bridge shows clear path to profitability; working capital release provides near-term cash cushion |
| Low | Low net-to-gross ratio | Large contractual allowances suggest pricing discipline issues. Mitigant: payer renegotiation is an additional upside lever |
8. Data Sources & Methodology Appendix
Data Sources
- CMS HCRIS Cost Reports (Medicare-certified hospitals)
- CMS Medicare Utilization (DRG-level volumes)
- CMS Chronic Conditions (county-level disease prevalence)
- HCRIS multi-year trend data (financial time series)
Comparable Selection
- 51 hospitals with 82-326 beds
- Same-state prioritization (n=52)
- Comp margins: P25=-17.3% / P50=-3.2% / P75=2.4%
Bridge Methodology
- Targets: P75 of comparable peers (60% gap closure)
- Denial: avoidable share = 35% of delta × NPR
- AR: bad debt coefficient = $0.65 per day per $1K NPR
- NCR: 60% coefficient on collection rate improvement
- CDI: 0.75% of Medicare revenue per 0.01 CMI point
Returns Assumptions
- Leverage: 5.5x entry (84.6% debt / 15.4% equity)
- Organic growth: 3% annual EBITDA growth
- Debt paydown: 10% of principal per year
- Hold period: 5 years
Generated by SeekingChartis on April 26, 2026. All predictions use public data only. Confidence intervals calibrated via split conformal prediction (90% coverage target). This memo is for informational purposes and does not constitute investment advice.